It’s been a rough year for job seekers. The last thing they wanted was a Spotify Wrapped-style reminder of that. They got one anyway, when LinkedIn launched an inaugural Year in Review. The summaries ...

This guide explains the meaning of every crusade map symbol in Cult of the Lamb, and it will make it easy for players to plan ...

President Trump on Thursday signed an executive order to speed up the rescheduling of marijuana from Schedule I to the less severe Schedule III, with the stated goal of expanding cannabis research.

President Donald Trump signed an executive order Thursday to expedite the reclassification of marijuana – an effort to increase research on its medical use but not fully legalize it. “This ...

President Trump is signing an executive order Thursday from the Oval Office that will drop marijuana into a lower drug classification — but it will not equate to full legalization. The move continues ...

WASHINGTON, Dec 15 (Reuters) - U.S. President Donald Trump said on Monday he is considering an executive order to reclassify marijuana as a less dangerous drug — a decision that could reshape the ...

WASHINGTON, Dec 18 (Reuters) - U.S. President Donald Trump on Thursday signed an order directing the loosening of federal regulations on marijuana, a move that could further reverse decades of ...

COACHELLA VALLEY, Calif. (KESQ) - President Trump signed an executive order Thursday to reclassify marijuana from a Schedule I to Schedule III drug, a move experts say would open new financial and ...

Matthieu Caron does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Sydney Bradley Every time Sydney publishes a story, you’ll get an alert straight to your inbox!

Section 1. Purpose and Policy. Americans deserve access to the best medical treatments and research infrastructure in the world. In 2023, the Food and Drug Administration (FDA) completed a review of ...